Mortality within 30 days of initiation of induction
. | Younger than 56 y . | 56-65 y . | 66-75 y . | Older than 75 y . |
|---|---|---|---|---|
| No. patients | 364 | 242 | 270 | 79 |
| Early deaths*by performance status, no./no. total patients (%) | ||||
| 0 | 3/129 (2) | 8/72 (11) | 9/73 (12) | 2/14 (14) |
| 1 | 6/180 (3) | 6/112 (5) | 20/126 (16) | 7/40 (18) |
| 2 | 1/46 (2) | 6/34 (18) | 16/52 (31) | 7/14 (50) |
| 3 | 0/9 (0) | 7/24 (29) | 9/19 (47) | 9/11 (82) |
. | Younger than 56 y . | 56-65 y . | 66-75 y . | Older than 75 y . |
|---|---|---|---|---|
| No. patients | 364 | 242 | 270 | 79 |
| Early deaths*by performance status, no./no. total patients (%) | ||||
| 0 | 3/129 (2) | 8/72 (11) | 9/73 (12) | 2/14 (14) |
| 1 | 6/180 (3) | 6/112 (5) | 20/126 (16) | 7/40 (18) |
| 2 | 1/46 (2) | 6/34 (18) | 16/52 (31) | 7/14 (50) |
| 3 | 0/9 (0) | 7/24 (29) | 9/19 (47) | 9/11 (82) |
Patients with known prestudy performance status are included.
Within 30 days of registration to the trial.